Rockwell Medical, Inc. (RMTI)
| Market Cap | 53.51M |
| Revenue (ttm) | 86.62M |
| Net Income (ttm) | -8.42M |
| Shares Out | 30.32M |
| EPS (ttm) | -0.36 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 177,714 |
| Open | 1.710 |
| Previous Close | 1.740 |
| Day's Range | 1.680 - 1.830 |
| 52-Week Range | 1.160 - 6.240 |
| Beta | 1.21 |
| Analysts | Strong Buy |
| Price Target | 7.00 (+296.6%) |
| Earnings Date | May 14, 2024 |
About RMTI
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid c... [Read more]
Full Company ProfileFinancial Performance
In 2023, RMTI's revenue was $83.61 million, an increase of 14.84% compared to the previous year's $72.81 million. Losses were -$8.44 million, -54.82% less than in 2022.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for RMTI stock is "Strong Buy." The 12-month stock price forecast is $7.0, which is an increase of 296.60% from the latest price.
News
Rockwell Medical Announces First Quarter 2024 Results, Raises 2024 Guidance
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical (Nasdaq: RMTI) today announced financial and operational results for the three months ended March 31, 2024.
Rockwell Medical Continues to Expand its Distribution Capabilities in Western United States
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical enters into a new direct supply agreement with one of the largest health systems in the Mountain West Region of the Uni...
Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its financial and operational results for the first quarter ended March 31, 2024 on Tuesday, May 14, 2024.
Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical enters into new and expanded distribution agreements with BioNuclear and Atlantic Medical International, respectively.
Rockwell Medical Named 'Great Place to Work' for Second Year in a Row
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced that it has been certified as a Great Place to Work® for the second year in a row.
Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes...
Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the fourth quarter and full-year ended December 31, 2023 on Thursday, March 21, 2024.
Rockwell Medical Amends Loan and Security Agreement with Innovatus Life Sciences Lending Fund
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Defers principal payments of $8M up to 3yrs, reduces Rockwell Medical's need for additional operating capital, and enhances the Company'...
Rockwell Medical Announces Third Quarter 2023 Results
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes...
Rockwell Medical Names Jesse Neri as Senior Vice President, Finance
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Jesse Neri has 20+ years' experience leading finance functions at both public and private companies.
Rockwell Medical Appoints Joan Lau, Ph.D. to the Company's Board of Directors
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Dr. Joan Lau brings 20+ years of experience as an entrepreneur scientist, CEO, operator, investor, and board member of public and privat...
Rockwell Medical to Release Third Quarter 2023 Results on Tuesday, November 14, 2023
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its financial and operational results for the third quarter ended September 30, 2023 on Tuesday, November ...
Rockwell Medical Enters into 3-Year Product Purchase Agreement with Centers for Dialysis Care
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #ESRD--Rockwell Medical is honored to be entrusted by Centers for Dialysis Care to be its preferred supplier of hemodialysis concentrates.
Rockwell Medical Enters into 3-Year Product Purchase Agreement with Sanderling Renal Services; Expands Distribution Capabilities Westward into Utah
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical is the preferred supplier of liquid and dry acid and bicarbonate hemodialysis concentrates to Sanderling Renal Services...
Rockwell Medical Enters into Products Purchase Agreement with its Largest Customer, Enhancing Relationship through 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced that it entered into an amended and restated products purchase agreement with its largest customer.
Rockwell Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's President and CEO, Dr. Mark Strobeck, will present at H.C. Wainwright's conference on September 12, 2023 at 11:00 am ...
Rockwell Medical Announces Second Quarter 2023 Results
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #Hemodialysis--Rockwell Medical updated its guidance on profitability and now expects the Company to be profitable in the fourth quarter 2023 and going forward.
Rockwell Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Rockwell Medical to Release Second Quarter 2023 Financial Results on Monday, August 14, 2023
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its financial and operational results for the second quarter ended June 30, 2023 on Monday, August 14, 202...
Rockwell Medical Acquires Hemodialysis Concentrates Business from Evoqua Water Technologies
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical acquires the hemodialysis concentrates business from Evoqua Water Technologies; Adds fully automated and profitable bus...
Rockwell Medical Announces 3-Year Co-Promotional Collaboration with B. Braun Medical
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #Collaboration--Rockwell Medical entered into a three-year co-promotion services agreement with B. Braun Medical Inc.
Rockwell Medical Added to Russell Microcap Index
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #RussellRecon--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfo...
Rockwell Medical Announces First Quarter 2023 Results
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical (Nasdaq: RMTI) today announced financial and operational results for the three months ended March 31, 2023.
Rockwell Medical Announces Global Expansion into the United Arab Emirates
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Geographic expansion, domestically and internationally, is a major focus for Rockwell Medical as we work to achieve profitability in 202...
Rockwell Medical's Partner Drogsan Pharmaceuticals Submits Marketing Authorization Application in Turkey for Triferic AVNU
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Drogsan Pharmaceuticals is making great strides in its plan to register and commercialize Triferic AVNU in Turkey.